| 标题 |
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Oncology 作者:David Olmos; Sophie Postel-Vinay; L Rhoda Molife; Scott H Okuno; Scott M Schuetze; et al 出版日期:2009-12-24 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)